Rostami-Nejad Mohammad, Romanos Jihane, Rostami Kamran, Ganji Azita, Ehsani-Ardakani Mohammad Javad, Bakhshipour Ali-Reza, Zojaji Homayoun, Mohebbi Seyed Reza, Zali Mohammad-Reza, Wijmenga Cisca
Mohammad Rostami-Nejad, Mohammad Javad Ehsani-Ardakani, Homayoun Zojaji, Seyed Reza Mohebbi, Mohammad-Reza Zali, Department of Celiac Disease, Gastroenterology and Liver Diseases Research Centers, Shahid Beheshti University of Medical Sciences, Tehran 1985717411, Iran.
World J Gastroenterol. 2014 May 28;20(20):6302-8. doi: 10.3748/wjg.v20.i20.6302.
To assess the distribution of human leukocyte antigen (HLA)-DQ2 and -DQ8 in Iranian celiac disease (CD) patients and compare them to healthy Iranian controls.
To predict the HLA-DQA1 and -DQB1 genes, we used six previously reported HLA-tagging single nucleotide polymorphism to determine HLA genotypes in 59 Iranian patients with 'biopsy-confirmed' CD and in 151 healthy Iranian individuals. To test the transferability of the method, 50 cases and controls were also typed using a commercial kit that identifies individual carriers of DQ2, DQ7 and DQ8 alleles.
In this pilot study 97% of CD cases (n = 57) and 58% of controls (n = 87) were carriers of HLA-DQ2 and/or HLA-DQ8 heterodimers, either in the homozygous or heterozygous state. The HLA-DQ pattern of these 57 CD patients: heterozygous DQ2.2 (n = 14) and homozygous DQ2.2 (n = 1), heterozygous DQ2.5 (n = 33) and homozygous DQ2.5 (n = 8), heterozygous DQ8 (n = 13) and homozygous DQ8 (n = 2). Two CD patients were negative for both DQ2 and DQ8 (3%).
The prevalence of DQ8 in our CD population was higher than that reported in other populations (25.4%). As reported in other populations, our results underline the primary importance of HLA-DQ alleles in the Iranian population's susceptibility to CD.
评估人类白细胞抗原(HLA)-DQ2和-DQ8在伊朗乳糜泻(CD)患者中的分布情况,并与伊朗健康对照者进行比较。
为预测HLA-DQA1和-DQB1基因,我们使用6个先前报道的HLA标签单核苷酸多态性来确定59例经活检确诊的伊朗CD患者和151名伊朗健康个体的HLA基因型。为测试该方法的可转移性,还使用了一种商业试剂盒对50例病例和对照进行分型,该试剂盒可识别DQ2、DQ7和DQ8等位基因的个体携带者。
在这项初步研究中,97%的CD病例(n = 57)和58%的对照者(n = 87)是HLA-DQ2和/或HLA-DQ8异二聚体的携带者,呈纯合或杂合状态。这57例CD患者的HLA-DQ模式为:杂合DQ2.2(n = 14)和纯合DQ2.2(n = 1),杂合DQ2.5(n = 33)和纯合DQ2.5(n = 8),杂合DQ8(n = 13)和纯合DQ8(n = 2)。两名CD患者DQ2和DQ8均为阴性(3%)。
我们的CD人群中DQ8的患病率高于其他人群报道的患病率(25.4%)。正如其他人群所报道的那样,我们的结果强调了HLA-DQ等位基因在伊朗人群对CD易感性中的首要重要性。